Shikonin-Cobalt Nanoparticle Data for Diabetic Wound Healing Experiments

A 955.0 KB document authored by Xiaoge Wang, last updated on 2026-04-22. It describes experimental results for self-assembled shikonin-cobalt nanoparticles, including in vitro cytotoxicity, reactive oxygen species scavenging, and in vivo wound healing rates in a diabetic model. The study provides data on nanoparticle effects on inflammatory factors, apoptosis rates, and collagen deposition.

Use Cases

• Benchmarking nanoparticle efficacy based on reported 95% wound healing rate by day 12.
• Studying antioxidant effects based on described reactive oxygen species scavenging and reduction of H2O2-induced apoptosis.
• Analyzing inflammatory response modulation based on data for IL-1β, TNF-α, and IL-10 levels.
• Evaluating material safety based on cytotoxicity data at a concentration of 16 mg/L.

Strengths

• Includes specific quantitative results, such as reducing apoptosis from 25.1% to 10.31%.
• Reports a concrete wound healing outcome of 95% by day 12 in animal experiments.
• Provides a clear material synthesis method via self-assembly.

Limitations

• Dataset scale is limited to a 955.0 KB document; underlying raw experimental data is not directly provided.
• Column-level documentation is absent; field semantics must be inferred from the descriptive text.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare, author Xiaoge Wang

Collection Method

Experimental study involving in vitro and in vivo evaluation of synthesized nanoparticles.

Freshness

Last updated 2026-04-22 05:49:47; freshness should be verified.